Detalhe da pesquisa
1.
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.
N Engl J Med
; 388(8): 694-705, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812433
2.
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
N Engl J Med
; 386(11): 1013-1025, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294811
3.
Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells.
Blood
; 142(3): 290-305, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192286
4.
Current and emerging gene therapies for haemophilia A and B.
Haemophilia
; 30 Suppl 3: 12-20, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528615
5.
Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice.
Cell Immunol
; 385: 104675, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746071
6.
Subclinical retinopathy in systemic lupus erythematosus patients - optical coherence tomography study.
Reumatologia
; 61(3): 161-168, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522138
7.
Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
J Biol Chem
; 296: 100299, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460651
8.
One of the two N-glycans on the human Gb3/CD77 synthase is essential for its activity and allosterically regulates its function.
Biochem Biophys Res Commun
; 617(Pt 1): 36-41, 2022 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35671609
9.
Gene therapy - are we ready now?
Haemophilia
; 28 Suppl 4: 35-43, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35521736
10.
Ludwik Hirszfeld: A pioneer of transfusion and immunology during the world wars and beyond.
Vox Sang
; 117(4): 467-475, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743351
11.
Missing the sweet spot: one of the two N-glycans on human Gb3/CD77 synthase is expendable.
Glycobiology
; 31(9): 1145-1162, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978735
12.
Management of COVID-19-associated coagulopathy in persons with haemophilia.
Haemophilia
; 27(1): 41-48, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216448
13.
A Molecular Revolution in the Treatment of Hemophilia.
Mol Ther
; 28(4): 997-1015, 2020 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843450
14.
Eph Receptors and Ephrins in Retinal Diseases.
Int J Mol Sci
; 22(12)2021 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201393
15.
The Role of Eph Receptors and Ephrins in Corneal Physiology and Diseases.
Int J Mol Sci
; 22(9)2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33925443
16.
Two Paralogous Gb3/CD77 Synthases in Birds Show Different Preferences for Their Glycoprotein and Glycosphingolipid Substrates.
Int J Mol Sci
; 22(18)2021 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34575935
17.
How glycosylation affects glycosylation: the role of N-glycans in glycosyltransferase activity.
Glycobiology
; 30(12): 941-969, 2020 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363402
18.
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table.
Haemophilia
; 26(3): 443-449, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32202382
19.
Immune tolerance induction by hepatic gene transfer: First-in-human evidence.
Mol Ther
; 32(4): 863-864, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518767
20.
Treatment-induced hemophilic thrombosis?
Mol Ther
; 30(2): 505-506, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063080